IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities

Sepsis remains a global clinical problem. By using the mouse cecal ligation and puncture model of sepsis, here we identify an important aspect of mast cell (MC)-dependent, innate immune defenses against Gram-negative bacteria by demonstrating that MC protease activity is regulated by interleukin-15...

Full description

Saved in:
Bibliographic Details
Published in:Nature medicine Vol. 13; no. 8; pp. 927 - 934
Main Authors: Schulmistrat, Jan, Bulanova, Elena, Mirghomizadeh, Farhad, Orinska, Zane, Bulfone-Paus, Silvia, Budagian, Vadim, Giron-Michel, Julien, Nashkevich, Natalia, Schiemann, Florian, Brandt, Ernst, Maurer, Marcus, Metz, Martin, Paus, Ralf
Format: Journal Article
Language:English
Published: United States Nature Publishing Group 01-08-2007
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sepsis remains a global clinical problem. By using the mouse cecal ligation and puncture model of sepsis, here we identify an important aspect of mast cell (MC)-dependent, innate immune defenses against Gram-negative bacteria by demonstrating that MC protease activity is regulated by interleukin-15 (IL-15). Mouse MCs express both constitutive and lipopolysaccharide-inducible IL-15 and store it intracellularly. Deletion of Il15 in mice markedly increases chymase activities, leading to greater MC bactericidal responses, increased processing and activation of neutrophil-recruiting chemokines, and significantly higher survival rates of mice after septic peritonitis. By showing that intracellular IL-15 acts as a specific negative transcriptional regulator of a mouse MC chymase (mast cell protease-2), we provide evidence that defined MC protease activity is transcriptionally regulated by an intracellularly retained cytokine. Our results identify an unexpected breach in MC-dependent innate immune defenses against sepsis and suggest that inhibiting intracellular IL-15 in MCs may improve survival from sepsis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1078-8956
1546-170X
DOI:10.1038/nm1615